A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)

NCT05624281 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Lung Diseases, Interstitial (in Pediatric Populations)
Childhood Interstitial Lung Disease (chILD)

Interventions

DRUG: nintedanib

Sponsor

Boehringer Ingelheim